First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant ...

LONDON - GlaxoSmithKline PLC (LSE/NYSE: NYSE:GSK) announced today that the European Medicines Agency (EMA) has begun ...

GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

The company said under a collaboration with the university it would invest £50m over three years to find out whether cancers ...

GSK has announced that a pre-filled syringe version of its Shingrix shingles vaccine has been accepted for review by the ...

Chinese regulators are investigating the quality of domestic generic drugs after a rare public backlash against a cost-cutting campaign that prioritised their use in the national healthcare system but ...

JD SPORTS reported pre-tax profits of £917.2 million (€1.1 billion) in 2023 and hoped for 2024 earnings of £1 billion (€1.19 ...

Colombia on Sunday backed down and agreed to accept deported citizens sent on US military aircraft, hours after President Trump threatened painful tariffs to punish the defiance to his mass ...

(Alliance News) - Pharmaceutical firm GSK PLC and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or ...

This European review of the prefilled syringe follows GSK's receipt of approval from the US Food & Drug Administration on January 8. GSK is also investigating submission of the new presentation to ...

Thailand’s pharmaceutical industry has emerged as a key sector in the nation’s economic and healthcare landscape, reflecting robust growth and strategic ...